NCT06464198

Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: University of Erlangen-Nürnberg Medical School · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective registry study based on a standard therapy concept for postoperative simultaneous radiochemotherapy established in Erlangen and elsewhere. The efficacy and tolerability of simultaneous postoperative radiochemotherapy is being investigated. Patients with locally advanced high-grade salivary gland carcinoma after oncological resection are admitted.

Conditions

• Locally Advanced Salivary Gland Carcinoma

Interventions

Type	Name	Description
PROCEDURE	simultaneous postoperative radiochemotherapy	The efficacy and tolerability of simultaneous postoperative radiochemotherapy is being investigated.

Timeline

• Start date: 2024-06-01
• Primary completion: 2036-06-01
• Completion: 2037-06-01
• First posted: 2024-06-18
• Last updated: 2026-03-13

Locations

1 site across 1 country: Germany